CONMED Corporation to Participate in a Fireside Chat at the Stifel 2022 Healthcare Conference

CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Stifel 2022 Healthcare Conference at 1:15 p.m.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Monday, November 7, 2022
Information
Tags: 
Medical Devices, Health, Surgery, Health Technology, General Health, Biotechnology, General surgery, AME Publishing Company, Physician, Industry, Company, Risk, Elective surgery, NYSE, Private Securities Litigation Reform Act, Board, Government, Form 10-Q, COVID-19, Gastroenterology, Gynaecology, Conference, Chairperson, Annual report, Surgeon
Geotags: 
UNITED STATES, NORTH AMERICA, FLORIDA
⚠ partially generated by AI ↴
Organisation: 
CONMED, CONMED CORPORATION
Stock Symbol: 
NYSE:CNMD
Summary
Key Points: 
  • CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Stifel 2022 Healthcare Conference at 1:15 p.m.
  • A live audio webcast of the fireside chat will be accessible through the Investors section of the Companys website at www.conmed.com and will be available for replay following the event.
  • CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures.
  • The Companys products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology.


CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Stifel 2022 Healthcare Conference at 1:15 p.m. ET on Tuesday, November 15, 2022.

A live audio webcast of the fireside chat will be accessible through the “Investors” section of the Company’s website at www.conmed.com and will be available for replay following the event.

About CONMED Corporation

CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company’s products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. For more information, visit www.conmed.com.

Forward-Looking Statements

This press release may contain forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. For example, in addition to general industry and economic conditions, factors that could cause actual results to differ materially from those in the forward-looking statements may include, but are not limited to, the risks posed to the Company’s business, financial condition, and results of operations by the COVID-19 global pandemic and the various government and other responses to the pandemic, including deferral of surgeries, reductions in hospital and ambulatory surgery center operating volumes, disruption to potential supply chain reliability, as well as the risk factors discussed in the Company's Annual Report on Form 10-K for the full year ended December 31, 2021 and listed under the heading Forward-Looking Statements in the Company’s most recently filed Form 10-Q. Any and all forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company’s performance on a going-forward basis. The Company believes that all forward-looking statements made by it have a reasonable basis, but there can be no assurance that management’s expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct.

Copyright: 
Copyright Business Wire 2022